nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—NME1—neck—salivary gland cancer	0.125	0.127	CbGeAlD
Adefovir Dipivoxil—AK4—saliva-secreting gland—salivary gland cancer	0.0943	0.0957	CbGeAlD
Adefovir Dipivoxil—NME1—connective tissue—salivary gland cancer	0.0899	0.0913	CbGeAlD
Adefovir Dipivoxil—SLC22A3—tongue—salivary gland cancer	0.0853	0.0866	CbGeAlD
Adefovir Dipivoxil—NME2—epithelium—salivary gland cancer	0.0804	0.0816	CbGeAlD
Adefovir Dipivoxil—NME1—lymphoid tissue—salivary gland cancer	0.0657	0.0667	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—lymph node—salivary gland cancer	0.0637	0.0647	CbGeAlD
Adefovir Dipivoxil—NME2—lymphoid tissue—salivary gland cancer	0.0619	0.0629	CbGeAlD
Adefovir Dipivoxil—AK2—lymph node—salivary gland cancer	0.0483	0.0491	CbGeAlD
Adefovir Dipivoxil—SLC22A3—parotid gland—salivary gland cancer	0.0399	0.0406	CbGeAlD
Adefovir Dipivoxil—SLC22A3—saliva-secreting gland—salivary gland cancer	0.0383	0.0388	CbGeAlD
Adefovir Dipivoxil—NME1—lymph node—salivary gland cancer	0.0371	0.0376	CbGeAlD
Adefovir Dipivoxil—AK4—lymph node—salivary gland cancer	0.0357	0.0363	CbGeAlD
Adefovir Dipivoxil—SLC22A3—connective tissue—salivary gland cancer	0.0352	0.0357	CbGeAlD
Adefovir Dipivoxil—NME2—lymph node—salivary gland cancer	0.0349	0.0355	CbGeAlD
Adefovir Dipivoxil—ABCC5—lymph node—salivary gland cancer	0.0203	0.0206	CbGeAlD
Adefovir Dipivoxil—SLC22A3—lymph node—salivary gland cancer	0.0145	0.0147	CbGeAlD
Adefovir Dipivoxil—ABCC4—lymph node—salivary gland cancer	0.0141	0.0143	CbGeAlD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—CDH1—salivary gland cancer	0.000452	0.0301	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—BCOR—salivary gland cancer	0.000412	0.0274	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—GAS6—salivary gland cancer	0.000411	0.0273	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—GAS6—salivary gland cancer	0.000391	0.026	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—CDH1—salivary gland cancer	0.000365	0.0243	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CREBBP—salivary gland cancer	0.000362	0.0241	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—salivary gland cancer	0.000359	0.0239	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Defective B3GAT3 causes JDSSDHD—ST3GAL4—salivary gland cancer	0.000339	0.0225	CbGpPWpGaD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—CCND1—salivary gland cancer	0.000337	0.0224	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—CREBBP—salivary gland cancer	0.000321	0.0213	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.000287	0.0191	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.000259	0.0172	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.000256	0.017	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—ISYNA1—salivary gland cancer	0.000256	0.017	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—CREBBP—salivary gland cancer	0.000243	0.0161	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Defective B3GAT3 causes JDSSDHD—VCAN—salivary gland cancer	0.000242	0.0161	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—PYGB—salivary gland cancer	0.000232	0.0154	CbGpPWpGaD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—PIK3CA—salivary gland cancer	0.00023	0.0153	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—EP300—salivary gland cancer	0.000218	0.0145	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.000216	0.0144	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—MARCKS—salivary gland cancer	0.000208	0.0138	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000205	0.0136	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PYGB—salivary gland cancer	0.000194	0.0129	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—GAS6—salivary gland cancer	0.000182	0.0121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000182	0.0121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—ST3GAL4—salivary gland cancer	0.000182	0.0121	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ISYNA1—salivary gland cancer	0.000177	0.0118	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—salivary gland cancer	0.000169	0.0112	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—EP300—salivary gland cancer	0.000165	0.011	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PHGDH—salivary gland cancer	0.000158	0.0105	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—TP53—salivary gland cancer	0.000156	0.0104	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—ST3GAL4—salivary gland cancer	0.000152	0.0101	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000146	0.0097	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—JMJD1C—salivary gland cancer	0.000146	0.00969	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—MARCKS—salivary gland cancer	0.000144	0.0096	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AQP1—salivary gland cancer	0.000138	0.00917	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000138	0.00917	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PYGB—salivary gland cancer	0.000134	0.00892	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ISYNA1—salivary gland cancer	0.000134	0.00892	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000132	0.00875	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—NUP62—salivary gland cancer	0.000131	0.0087	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—VCAN—salivary gland cancer	0.00013	0.00863	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—TP53—salivary gland cancer	0.000129	0.00854	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000126	0.00839	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00012	0.00797	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TP53—salivary gland cancer	0.000118	0.00787	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00011	0.0073	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PHGDH—salivary gland cancer	0.000109	0.00727	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—NUP62—salivary gland cancer	0.000109	0.00727	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—MARCKS—salivary gland cancer	0.000109	0.00727	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—VCAN—salivary gland cancer	0.000109	0.00722	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ST3GAL4—salivary gland cancer	0.000105	0.007	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.000105	0.00695	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PYGB—salivary gland cancer	0.000102	0.00676	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AQP1—salivary gland cancer	9.57e-05	0.00636	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	9.43e-05	0.00627	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—GAS6—salivary gland cancer	9.4e-05	0.00624	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—GUCY1A3—salivary gland cancer	9.4e-05	0.00624	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TP53—salivary gland cancer	8.91e-05	0.00592	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	8.87e-05	0.0059	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	8.56e-05	0.00569	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—AQP1—salivary gland cancer	8.36e-05	0.00556	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PHGDH—salivary gland cancer	8.3e-05	0.00551	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	8.17e-05	0.00543	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ST3GAL4—salivary gland cancer	7.99e-05	0.00531	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	7.87e-05	0.00523	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—NUP62—salivary gland cancer	7.59e-05	0.00504	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—VCAN—salivary gland cancer	7.53e-05	0.005	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ISYNA1—salivary gland cancer	7.25e-05	0.00482	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AQP1—salivary gland cancer	7.25e-05	0.00482	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—WNT5B—salivary gland cancer	6.79e-05	0.00451	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—AQP1—salivary gland cancer	6.71e-05	0.00446	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—NUP62—salivary gland cancer	6.63e-05	0.00441	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL17RD—salivary gland cancer	6.56e-05	0.00436	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PYGB—salivary gland cancer	6.56e-05	0.00436	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CPSF4—salivary gland cancer	6.56e-05	0.00436	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—AQP1—salivary gland cancer	6.04e-05	0.00402	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	6.04e-05	0.00401	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAML3—salivary gland cancer	6e-05	0.00399	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MARCKS—salivary gland cancer	5.91e-05	0.00393	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	5.84e-05	0.00388	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ISYNA1—salivary gland cancer	5.82e-05	0.00386	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—AQP1—salivary gland cancer	5.8e-05	0.00385	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—NUP62—salivary gland cancer	5.75e-05	0.00382	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—VCAN—salivary gland cancer	5.71e-05	0.00379	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MYB—salivary gland cancer	5.59e-05	0.00371	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PYGB—salivary gland cancer	5.5e-05	0.00365	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—NUP62—salivary gland cancer	5.32e-05	0.00353	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ST3GAL4—salivary gland cancer	5.15e-05	0.00342	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—AQP1—salivary gland cancer	5.05e-05	0.00335	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—NUP62—salivary gland cancer	4.79e-05	0.00319	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MARCKS—salivary gland cancer	4.74e-05	0.00315	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—DTX4—salivary gland cancer	4.68e-05	0.00311	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—NUP62—salivary gland cancer	4.6e-05	0.00305	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PHGDH—salivary gland cancer	4.48e-05	0.00298	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PYGB—salivary gland cancer	4.41e-05	0.00293	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ST3GAL4—salivary gland cancer	4.31e-05	0.00287	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CREBBP—salivary gland cancer	4.25e-05	0.00282	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—NUP62—salivary gland cancer	4e-05	0.00266	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AQP1—salivary gland cancer	3.92e-05	0.0026	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGF16—salivary gland cancer	3.87e-05	0.00257	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NUP62—salivary gland cancer	3.71e-05	0.00246	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—VCAN—salivary gland cancer	3.68e-05	0.00244	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PHGDH—salivary gland cancer	3.59e-05	0.00239	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ST3GAL4—salivary gland cancer	3.46e-05	0.0023	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAML2—salivary gland cancer	3.36e-05	0.00223	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AQP1—salivary gland cancer	3.14e-05	0.00209	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NUP62—salivary gland cancer	3.11e-05	0.00206	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—VCAN—salivary gland cancer	3.08e-05	0.00205	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTEN—salivary gland cancer	3.03e-05	0.00201	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CREBBP—salivary gland cancer	2.94e-05	0.00196	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—EP300—salivary gland cancer	2.89e-05	0.00192	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—JAG1—salivary gland cancer	2.87e-05	0.00191	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGFR4—salivary gland cancer	2.86e-05	0.0019	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FBXW7—salivary gland cancer	2.81e-05	0.00187	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	2.57e-05	0.00171	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NUP62—salivary gland cancer	2.49e-05	0.00165	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—VCAN—salivary gland cancer	2.47e-05	0.00164	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FOXO3—salivary gland cancer	2.37e-05	0.00158	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CREBBP—salivary gland cancer	2.23e-05	0.00148	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CA—salivary gland cancer	2.14e-05	0.00142	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTEN—salivary gland cancer	2.1e-05	0.0014	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	2.06e-05	0.00137	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CREBBP—salivary gland cancer	2.06e-05	0.00137	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	2.01e-05	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—EP300—salivary gland cancer	2e-05	0.00133	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAP2K2—salivary gland cancer	1.94e-05	0.00129	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.86e-05	0.00124	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.78e-05	0.00118	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTEN—salivary gland cancer	1.59e-05	0.00106	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOTCH1—salivary gland cancer	1.59e-05	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.55e-05	0.00103	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—EP300—salivary gland cancer	1.52e-05	0.00101	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CA—salivary gland cancer	1.48e-05	0.000985	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CREBBP—salivary gland cancer	1.44e-05	0.000955	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—EP300—salivary gland cancer	1.4e-05	0.000932	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CREBBP—salivary gland cancer	1.2e-05	0.0008	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CA—salivary gland cancer	1.12e-05	0.000746	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CA—salivary gland cancer	1.04e-05	0.000689	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTEN—salivary gland cancer	1.03e-05	0.000682	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—salivary gland cancer	1e-05	0.000667	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EP300—salivary gland cancer	9.79e-06	0.000651	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CREBBP—salivary gland cancer	9.66e-06	0.000642	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HRAS—salivary gland cancer	9.6e-06	0.000638	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTEN—salivary gland cancer	8.6e-06	0.000571	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—EP300—salivary gland cancer	8.2e-06	0.000545	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CA—salivary gland cancer	7.24e-06	0.000481	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTEN—salivary gland cancer	6.9e-06	0.000458	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HRAS—salivary gland cancer	6.7e-06	0.000445	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—EP300—salivary gland cancer	6.58e-06	0.000437	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CA—salivary gland cancer	6.07e-06	0.000403	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CA—salivary gland cancer	4.87e-06	0.000323	CbGpPWpGaD
